Riskpilot← Back to searchSign inGet full accessKonsigyn AB
ABActiveOrg 5565403192Vasagatan 12 DMedical specialists activities · NACE 8622Est. 19971 employees
Revenue 2025
SEK 163K
-44% vs 2024
EBITDA margin
75.2%
-53% vs 2024
Equity ratio
18.0%
Financial strength
Net profit 2025
SEK 104K
-31% vs 2024
| Revenue | SEK 163K | -44% |
| EBITDA | SEK 123K | -53% |
| Net profit | SEK 104K | -31% |
| Total assets | SEK 1,3M | -14% |
| Equity | SEK 226K | -46% |
| Employees | 1 | — |
Legal name
Konsigyn AB
Org number
5565403192
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 april 1997
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkartjänster samt därmed förenlig verksamhet.
Address
Vasagatan 12 D
Phone
+4646131843
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 446 | 661 | 247 | 292 | 163 |
| Staff expenses | — | −10 | −8 | −3 | −7 |
| EBITDA | 399 | 621 | 193 | 261 | 123 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 399 | 621 | 193 | 261 | 123 |
| Net financials | 4 | 2 | −1 | 1 | 8 |
| Profit before tax | 301 | 467 | 412 | 193 | 135 |
| Tax | −71 | −97 | −94 | −43 | −31 |
| Net profit | 230 | 370 | 319 | 150 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 302 | 1 982 | 1 284 | 1 467 | 1 258 |
| Equity | 352 | 492 | 560 | 422 | 226 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 343 | 726 | 179 | 431 | 423 |
| Total debt | 343 | 726 | 179 | 431 | 423 |
EBITDA margin
75.2%
This company
15.8%
Market median
+376% vs market
20212025
Equity ratio
18.0%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
46.0%
This company
18.4%
Market median
+150% vs market
20212025
Net profit margin
63.8%
This company
8.1%
Market median
+688% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
4.56×
This company
0.62×
Market median
-635% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2021 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Konsigyn AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eivor Görel Ingegerd Ingstorp | Audit | 0 companies |
| Anna Charlotta Ulrika Steinwall | Deputy Board Member | 0 companies |
| Ebba Clara Margareta Steinwall | Board of Directors | 0 companies |